Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
D1njxytayUGJwaNW